Apellis Pharmaceuticals Cash from Investing (Quarterly) Analysis

Apellis Pharmaceuticals Inc (APLS)

41.99 -0.53 (-1.25%) USD | NASDAQ | May 10, 16:00

41.98 -0.01 (-0.02%) After-Hours: 20:00

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	-0.293M
December 31, 2023	0.004M
September 30, 2023	-0.047M
June 30, 2023	-0.372M
March 31, 2023	-0.259M
December 31, 2022	124.13M
September 30, 2022	124.78M
June 30, 2022	82.93M
March 31, 2022	-271.95M
December 31, 2021	84.98M
September 30, 2021	179.65M
June 30, 2021	129.75M
March 31, 2021	-146.76M

Date	Value
December 31, 2020	-0.091M
September 30, 2020	198.76M
June 30, 2020	-287.81M
March 31, 2020	-227.85M
December 31, 2019	-0.155M
September 30, 2019	-0.471M
June 30, 2019	-0.192M
March 31, 2019	-0.875M
December 31, 2018	0.00
September 30, 2018	0.00
June 30, 2018	0.00
March 31, 2018	0.00

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-287.81M

Minimum

Jun 2020

198.76M

Maximum

Sep 2020

-0.5633M

Average

-0.123M

Median

Cash from Investing (Quarterly) Benchmarks

Blueprint Medicines Corp	77.13M
Sarepta Therapeutics Inc	218.80M
Inspire Medical Systems Inc	-19.54M
Alnylam Pharmaceuticals Inc	-67.62M
Biomarin Pharmaceutical Inc	-14.24M

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-132.98M
Cash from Financing (Quarterly)	108.21M
Free Cash Flow	-550.90M
Free Cash Flow Per Share (Quarterly)	-1.084
Free Cash Flow to Equity (Quarterly)	-133.35M
Free Cash Flow to Firm (Quarterly)	-129.60M
Free Cash Flow Yield	-10.85%